Colin John Meyer, Chief Innovation Officer at REATA PHARMACEUTICALS INC (RETA), sold 5,480 shares at $168.74 ($926K) on 2023-08-16, disclosed to the SEC on 2023-08-17.
Open-market sale of $926k RETA by Chief Innovation Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $169.07 | 2,144 | $362K | 39.1% |
| 2 | $169.07 | 2,144 | $362K | 39.1% |
| 3 | $168.74 | 596 | $101K | 10.9% |
| 4 | $168.74 | 596 | $101K | 10.9% |
| Total | $169.00 avg | 5,480 | $926K | 100% |
| Filing → |
| RETA | SELL | 2023-03-06 | $16.3M | — | Filing → |
| RETA | SELL | 2021-06-16 | $16.4M | — | Filing → |
| RETA | SELL | 2020-11-18 | $8.0M | — | Filing → |